EIS vs. THNR ETF Comparison
Comparison of iShares MSCI Israel Capped Investable Market Index Fund (EIS) to Amplify Weight Loss Drug & Treatment ETF (THNR)
EIS
iShares MSCI Israel Capped Investable Market Index Fund
EIS Description
The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI Israel Capped Investable Market Index (the "underlying index"). The fund will at all times invest at least 90% of its assets in the securities of the underlying index or in depositary receipts representing securities in its underlying index. The underlying index is a custom, free float-adjusted market capitalization index designed to measure broad-based equity market performance in Israel. The underlying index consists of stocks traded primarily on the Tel Aviv Stock Exchange. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$61.24
Average Daily Volume
15,629
21
THNR
Amplify Weight Loss Drug & Treatment ETF
THNR Description
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.Grade (RS Rating)
Last Trade
$25.89
Average Daily Volume
10,960
7
Performance
Period | EIS | THNR |
---|---|---|
30 Days | -0.70% | 1.44% |
60 Days | 3.32% | |
90 Days | 2.99% | |
12 Months | 15.66% |
0 Overlapping Holdings
Symbol | Grade | Weight in EIS | Weight in THNR | Overlap |
---|
EIS Overweight 21 Positions Relative to THNR
EIS: Top Represented Industries & Keywords
THNR: Top Represented Industries & Keywords